Frequently Asked Questions
This FAQ document responds to the following Frequently Asked Questions on PCP:
- (1) What is R&D procurement, in particular PCP?
- (2) Is R&D procurement really underutilized in Europe?
- (3) What makes PCP interesting for public procurers?
- (4) What are the potential benefits of PCP for industry?
- (5) What can PCP do for citizens and policy makers?
- (6) Who are the main actors in PCP?
- (7) How to overcome the main obstacles that have hindered widespread implementation of PCP in Europe so far?
- (8) How can I ensure in practice to procure R&D services "at market conditions"?
- (9) Does the cost of the multi-supplier approach of PCP not outweigh the benefits?
- (10) How to marry the "long term" nature of R&D with "short term" political election cycles?
- (11) What benefits can PCP bring specifically to the "local" economy?
- (12) What is the difference between PCP and the US SBIR program?
- (13) Why is it interesting for SMEs to participate in a PCP?
- (14) Fragmentation of public demand is an issue in Europe. Does PCP address this?
- (15) Is bundling/defragmentation of demand in PCP positive or negative for SMEs?
- (16) Why use procurement of R&D in addition to grants for R&D?
This page is maintained by: Lieve Bos